M/22/049 – Uniphar/LXV Remedies (Sam McCauley)

Transaction details

The proposed acquisition by Uniphar plc, through its wholly-owned subsidiary Trennamally Limited, of LXV Remedies Holdings Limited has been cleared by the Competition and Consumer Protection Commission subject to a number of legally binding commitments.

Notification date Decision date
Monday September 19, 2022 Friday, January 20, 2023
Parties Involved Business activities
Uniphar plc

Headquartered in Dublin, Uniphar is an Irish-incorporated public limited company traded on Euronext Dublin and the London Stock Exchange. It is an international diversified healthcare services business, servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three sectors/divisions - commercial & clinical, product access and supply chain & retail.

LXV Remedies Holdings Limited

LXV Remedies is the ultimate parent company of Sam McCauley Chemists Limited. Sam McCauley owns and operates a group of 37 retail pharmacies located across Leinster, Munster and Ulster. All of the 37 pharmacies trade under the name McCauley Health & Beauty Pharmacy.

Economic sector Media merger
Healthcare No
Submissions from third parties due by:
Phase 1 Phase 2
Tuesday, October 4, 2022
Current status: Completed
Cleared with agreed measures (Phase 1)
Authorised Officer Assigned Contact Details
Jason McGoldrick


Media enquiries: communications@ccpc.ie

Return to Merger Notifications

Haven’t found what you’re looking for?